HDAC4 and ovarian carcinoma: Over-expressed histone deacetylase 4 (HDAC4) interacted with STAT1, decreasing the levels of STAT1 acetylation and promoting STAT1 nuclear localization, thereby leading to cisplatin resistance in ovarian cancers 39.